Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

Also called NCT02364310

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 132 participants (enrolled count) (from the registry)
Sponsor
Pr Patrick ROSSIGNOL (from the registry)
Registry
  • NCT NCT02364310
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02364310. Randomized; no masking; primary purpose treatment. Start 2015-03-31 (actual); primary completion 2021-06-22 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Economic Evaluation of Baroreceptor STIMulation for the Treatment of Resistant HyperTensioN
Acronym
ESTIM-rHTN
Condition
Hypertension
Intervention (Device)
Baroreceptor stimulation with Barostim Neo TM
Lead sponsor
Pr Patrick ROSSIGNOL (class: other)

Record details

Record id
cardio:ct-nct02364310
Content hash
1c5b829d4efbb19403c1835b672d1a0b3716dd2de235cf56cfd6caeda6a36993